Vaxart Inc.

NASDAQ: VXRT · Real-Time Price · USD
0.49
-0.04 (-7.98%)
At close: Jun 27, 2025, 3:59 PM

Vaxart Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
28.7M 7.38M 107K 892K
Cost of Revenue
n/a n/a 3.27M 48.75M
Gross Profit
28.7M 7.38M -3.16M -47.86M
Operating Income
-66.29M -83.35M -114.59M -72.75M
Interest Income
2.54M 2.65M 1.25M 81K
Pretax Income
-66.69M -82.2M -107.69M -70.36M
Net Income
-66.95M -82.47M -107.76M -70.47M
Selling & General & Admin
20.78M 22.58M 29.39M 21.89M
Research & Development
74.21M 68.14M 81.05M 48.75M
Other Expenses
n/a n/a 6.96M 3.79M
Operating Expenses
94.99M 90.73M 110.44M 70.64M
Interest Expense
2.97M 1.45M 1.3M 1.48M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
94.99M 90.73M 110.44M 70.64M
Income Tax Expense
260K 261K 67K 107K
Shares Outstanding (Basic)
2.02B 1.45B 1.28B 1.21B
Shares Outstanding (Diluted)
2.02B 1.45B 1.28B 1.21B
EPS (Basic)
-0.03 -0.06 -0.08 -0.06
EPS (Diluted)
-0.03 -0.06 -0.08 -0.06
EBITDA
-54.87M -72.13M -103.12M -66.45M
EBIT
-63.72M -80.76M -106.39M -68.88M
Depreciation & Amortization
8.85M 8.62M 3.27M 2.43M